Pfizer (PFE) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

93
on a 30–98 scale
STRONG BUY
$28.83last close
+0score vs prior day
45–94range since 06-29
+18.3%price since 06-29

The entry score measures one thing: how far Pfizer's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Pfizer's price sits 1.37 ATR below its 20-day average ($29.83); it trades above its 200-day average ($26.97); its 14-day RSI is 49; it has moved -2.54% over 20 sessions; our regime filter classifies it as no confirmed trend.

Is Pfizer (PFE) a buy right now?

Pfizer scores 93/98 (Strong Buy) as of 2026-11-12; it is 6.4% below its 52-week high of $30.79; it is above its 200-day average; it moved -1.91% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1293+0$28.83
2026-11-0693+9$29.39
2026-11-0584+16$29.88
2026-11-0468-12$30.79
2026-11-0380+19$30.00
2026-11-0261-10$30.67
2026-10-2971-9$29.95
2026-10-2880+9$29.45
2026-10-2771+1$29.80
2026-10-2670+8$29.79
2026-10-2362+10$30.03
2026-10-2252-12$30.42

Congress trades in PFE

STOCK Act disclosures by members of Congress, cross-referenced from our Smart Money tracker.

TradedPoliticianTypeAmountReturn since
2026-09-04Rohit Khanna (D)SALE$1,001 - $15,000+3.3%

Related stocks

See today's full rankings + entry plan for PFE →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.